Deborah Stovall
Family · Princeton, KYNPI 1366908519
Payments from drug & device makers
Across 86 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$918
- Lilly USA, LLC$225
- Novo Nordisk$191
- Vanda Pharmaceuticals Inc.$74
- Amgen$72
- Axsome Therapeutics, Inc.$71
- plus $260 from 13 others
What the payments were for
- Food & beverage$1,811100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $918 |
| Lilly USA, LLC | 5 | $225 |
| Novo Nordisk | 5 | $191 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Amgen | 1 | $72 |
| Axsome Therapeutics, Inc. | 3 | $71 |
| Biohaven Pharmaceuticals, Inc. | 3 | $47 |
| Ironshore Pharmaceuticals Inc. | 2 | $33 |
| AstraZeneca | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Dexcom, Inc. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| GSK | 1 | $16 |
| Novartis | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $13 |
| Pfizer | 1 | $13 |
| Genentech USA, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,811 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $176,389 |
| OzempicSemaglutide | 32 | $32,076 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $31,302 |
| JardianceEmpagliflozin | 14 | $22,826 |
| MounjaroTirzepatide | 12 | $16,750 |
| EliquisApixaban | 12 | $12,778 |
| NexiumEsomeprazole Magnesium | 12 | $3,069 |
| Levothyroxine Sodium | 94 | $1,779 |
| Tramadol Hcl | 16 | $1,113 |
| Tizanidine Hcl | 17 | $892 |
| SynthroidLevothyroxine Sodium | 11 | $878 |
| Memantine Hcl | 57 | $714 |
| Ondansetron OdtOndansetron | 17 | $625 |
| Donepezil Hcl | 46 | $609 |
| Aripiprazole | 12 | $586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $191 | $32,07632 claims |
| GSKTrelegy Ellipta | $16 | $31,30233 claims |
| Lilly USA, LLCMounjaro | $225 | $16,75012 claims |
| PfizerEliquis | $13 | $12,77812 claims |
| AstraZenecaNexium | $31 | $3,06912 claims |
| AbbVieSynthroid | $918 | $87811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,374 family providers in Kentucky.
Other family in Princeton
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.